Hemorrhage is a leading cause of maternal mortality worldwide representing 27.1% maternal deaths in addition to inflicting considerable morbidity to the patient.
Every 6 minutes a woman in the world dies from postpartum related maternal health.
Improving maternal health is part of the United Nations 'Sustainable Development Goals (SDGs)'.
TXA use for treatment of PPH has been endorsed and recommended by the WHO in 2017 following the results of the largest trial addressing treatment of postpartum hemorrhage, the WOMAN trial.